NOD2 prevents emergence of disease-predisposing microbiota

Gut Microbes

Volumn 4, Issue 4, 2013, Pages 353-356

  Secher, Thomas ^a   Normand, Sylvain ^b,c,d   Chamaillard, Mathias ^b,c,d  

^a CEMAGREF   (France)

^b UNIV LILLE   (France)

^c INSERM U1019   (France)

^d INSERM   (France)

Author keywords

Colorectal cancer; Crohn disease; Dysbiosis; Fecal transplantation; Nucleotide binding oligomerization domain protein 2

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE RECEPTOR ANTAGONIST;

ACTINOBACTERIA; ADAPTIVE IMMUNITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEROIDETES; COLORECTAL CANCER; COMMENSAL; CROHN DISEASE; DISEASE PREDISPOSITION; FECES MICROFLORA; FIRMICUTES; GENE; HUMAN; INFLAMMATION; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE INFECTION; MICROBIOME; NONHUMAN; PROPHYLAXIS; SYMBIOSIS;

COLORECTAL CANCER; CROHN DISEASE; DYSBIOSIS; FECAL TRANSPLANTATION; NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN PROTEIN 2;

ANIMALS; COLITIS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; NOD2 SIGNALING ADAPTOR PROTEIN; PREGNANCY;

EID: 84880453358     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.25275     Document Type: Article

References (43)

1. Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, et al. Evolution of mammals and their gut microbes. Science 2008; 320:1647-1651; PMID:18497261; http://dx.doi.org/10.1126/sci-ence.1155725.
2. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al.; MetaHIT Consortium. Enterotypes of the human gut microbiome. Nature 2011; 473:174-180; PMID:21508958; http://dx.doi.org/10.1038/nature09944.
3. Lay C, Rigottier-Gois L, Holmstrøm K, Rajilic M, Vaughan EE, de Vos WM, et al. Colonic micro-biota signatures across five northern European countries. Appl Environ Microbiol 2005; 71:4153-5; PMID:16000838; http://dx.doi.org/10.1128/AEM.71.7.4153-4155.2005.
4. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486:222-7; PMID:22699611.
5. Fallani M, Young D, Scott J, Norin E, Amarri S, Adam R, et al.; Other Members of the INFABIO Team. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr 2010; 51:77-84; PMID:20479681; http://dx.doi.org/10.1097/MPG.0b013e3181d1b11e
6. Adlerberth I. Factors influencing the establishment of the intestinal microbiota in infancy. Nestle Nutr Workshop Ser Pediatr Program 2008; 62:13-29, discussion 29-33; PMID:18626190; http://dx.doi.org/10.1159/000146245
7. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118:511-521; PMID:16882802; http://dx.doi.org/10.1542/peds.2005-2824
8. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen Y Y, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334:105-8; PMID:21885731; http://dx.doi.org/10.1126/science.1208344
9. Muegge BD, Kuczynski J, Knights D, Clemente JC, González A, Fontana L, et al. Diet drives convergence in gut microbiome functions across mammalian phy-logeny and within humans. Science 2011; 332:970-4; PMID:21596990; http://dx.doi.org/10.1126/sci-ence.1198719
10. Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet JP, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 2009; 11:2574-2584; PMID:19601958; http://dx.doi.org/10.1111/j.1462-2920.2009.01982. x
11. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human micro-biome. Nature 2012; 486:207-214; PMID:22699609; http://dx.doi.org/10.1038/nature11234
12. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al.; MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65; PMID:20203603; http://dx.doi.org/10.1038/nature08821
13. Maurice CF, Haiser HJ, Turnbaugh PJ. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 2013; 152:39-50; PMID:23332745; http://dx.doi.org/10.1016/jcell.2012.10.052
14. Schloissnig S, Arumugam M, Sunagawa S, Mitreva M, Tap J, Zhu A, et al. Genomic variation landscape of the human gut microbiome. Nature 2013; 493:45-50; PMID:23222524; http://dx.doi.org/10.1038/nature11711
15. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331:337-341; PMID:21205640;http://dx.doi.org/10.1126/science.1198469
16. Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, Donermeyer DL, et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 2011; 9:390-403; PMID:21575910;http://dx.doi.org/10.1016/j.chom.2011.04.009
17. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human micro-biota. Science 2011; 332:974-7; PMID:21512004; http://dx.doi.org/10.1126/science.1206095
18. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012; 336:1268-1273; PMID:22674334; http://dx.doi.org/10.1126/science.1223490
19. Kamada N, Kim YG, Sham HP, Vallance BA, Puente JL, Martens EC, et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 2012; 336:1325-9; PMID:22582016; http://dx.doi.org/10.1126/sci-ence.1222195
20. Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006; 313:1126-1130; PMID:16931762; http://dx.doi.org/10.1126/science.1127119
21. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012; 488:178-184; PMID:22797518; http://dx.doi.org/10.1038/nature11319
22. Smith MI, Yatsunenko T, Manary MJ, Trehan I, Mkakosya R, Cheng J, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013; 339:548-554; PMID:23363771; http://dx.doi.org/10.1126/science.1229000.
23. Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 2012; 487:477-481; PMID:22837003; http://dx.doi.org/10.1038/nature11228.
24. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013; 339:1084-8; PMID:23328391; http://dx.doi.org/10.1126/science.1233521.
25. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut micro-biota in type 2 diabetes. Nature 2012; 490:55-60; PMID:23023125; http://dx.doi.org/10.1038/nature11450
26. Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012; 9:599-608; PMID:22907164; http://dx.doi.org/10.1038/nrgastro.2012.152.
27. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126:1504-1517; PMID:15168363; http://dx.doi.org/10.1053/j.gastro.2004.01.063.
28. Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006; 130:1030-8; PMID:16618396; http://dx.doi.org/10.1053/j.gastro.2005.12.035.
29. Khan KJ, Ullman TA, Ford AC, Abreu MT, Abadir A, Marshall JK, et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 2011; 106:661-673; PMID:21407187; http://dx.doi.org/10.1038/ajg.2011.72.
30. Asquith M, Powrie F. An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer. J Exp Med 2010; 207:1573-7; PMID:20679404; http://dx.doi.org/10.1084/jem.20101330.
31. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009; 7:887-894; PMID:19898491; http://dx.doi.org/10.1038/nrmicro2245.
32. Scanlan PD, Shanahan F, O'Mahony C, Marchesi JR. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol 2006; 44:3980-8; PMID:16988018; http://dx.doi.org/10.1128/JCM.00312-06.
33. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006; 55:205-211; PMID:16188921; http://dx.doi.org/10.1136/gut.2005.073817.
34. Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 2011; 11:7; PMID:21219646; http://dx.doi.org/10.1186/1471-2180-11-7.
35. Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011; 60:631-7; PMID:21209126; http://dx.doi.org/10.1136/gut.2010.223263.
36. Petnicki-Ocwieja T, Hrncir T, Liu YJ, Biswas A, Hudcovic T, Tlaskalova-Hogenova H, et al. Nod2 is required for the regulation of commensal micro-biota in the intestine. Proc Natl Acad Sci U S A 2009; 106:15813-8; PMID:19805227; http://dx.doi.org/10.1073/pnas.0907722106.
37. Mondot S, Barreau F, Al Nabhani Z, Dussaillant M, Le Roux K, Doré J, et al. Altered gut microbiota composition in immune-impaired Nod2(-/-) mice. Gut 2012; 61:634-5; PMID:21868489; http://dx.doi.org /10.1136 /gutjn l-2011-300478.
38. Rehman A, Sina C, Gavrilova O, Häsler R, Ott S, Baines JF, et al. Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011; 60:1354-1362; PMID:21421666; http://dx.doi.org/10.1136/gut.2010.216259.
39. Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, Chen H, et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2011; 17:179-184; PMID:20839241; http://dx.doi.org/10.1002/ibd.21339.
40. Couturier-Maillard A, Secher T, Rehman A, Normand S, De Arcangelis A, Haesler R, et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 2013; 123:700-711; PMID:23281400.
41. Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, Crawford RW, et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 2010; 467:426-9; PMID:20864996; http://dx.doi.org/10.1038/nature09415.
42. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012; 338:120-3; PMID:22903521; http://dx.doi.org/10.1126/sci-ence.1224820.
43. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489:220-230; PMID:22972295; http://dx.doi.org/10.1038/nature11550.